Appointment of Joint Corporate Broker

In brief · summary, not quotable

Coiled Therapeutics plc has appointed Shore Capital Stockbrokers Limited as a joint corporate broker, effective immediately, to work alongside existing brokers SP Angel Corporate Finance LLP and CPS Capital Group Pty Ltd. This strategic move aims to enhance the company's financial advisory and brokerage support as it progresses its clinical-stage precision oncology therapies.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes

Coiled Therapeutics (AIM: COIL) (OTCQB: COTXF), the clinical-stage precision oncology company developing differentiated small molecule therapies for genetically defined cancers, is pleased to announce the appointment of Shore Capital Stockbrokers Limited ("Shore Capital") as a joint corporate broker with immediate effect.

Shore Capital will act alongside the Company's existing nominated adviser and joint broker, SP Angel Corporate Finance LLP, and joint broker, CPS Capital Group Pty Ltd.

About AO-252

For more information, please visit: www.coiledplc.com and follow us on LinkedIn.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.